11:53 AM ET SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Into Possible Violations of Federal Securities Laws by Certain Officers and Directors of Juno Therapeutics Inc.
9:09 AM ET Shareholder Alert: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Juno Therapeutics Inc. - JUNOPR Newswire
9:04 AM ET U.S. Hot Stocks: Hot Stocks to WatchDow Jones
Why they need add chemo combination for treatment? That May indicate the efficiency CART treatment is not good. And combination may be dangerous and mono-treatment may be not efficacy enough. Than what USELESS is the answer